In what some patent holders are hoping will be a harbinger of things to come, publicly traded IP licensing companies are enjoying an unusually strong
Category: News
“Building an Innovation Economy” is focus of latest Hoover IP² event
IP², an initiative of the Hoover Institution at Stanford University, last week hosted a more than 60 IP scholars, economists and practitioners to hear and challenge research
Media use of patent “troll” is unfair says professor in Stanford Technology Law Review
The use of inaccurate, prejudicial language by newspapers, business publications and technology magazines to describe patent licensing activity biases readers and courts. That is among
Brody/Berman-mentored Fruti-Cycle wins LES business competition
Fruiti-Cycle Project, an Ungandan start-up that has developed an affordable bio-gas powered, refrigerated tricycle that speeds to market delivery of fruits and vegetables, has won
The “new normal” is focus of IP Business Congress in Barcelona
With traditional patent strategies under pressure to show that they are still relevant, business as usual in the IP space is no longer the same.
LES members have until Monday to vote on business plan competition
The LES Foundation International Business Plan Competition Members’ Choice award will conclude on Monday, April 25. LES members who have not voted still can. Competitor videos
Automobile industry convergence is the focus of Detroit IP conference
Over the past ten years or so the motor car of the 20th century has been transformed from a mechanical conveyance to a high-speed information
Patent licensing index significantly outperformed the S&P 500 in Q1
The eagerly sought bottom for publicly traded patent licensing companies may have been reached according to the data provided by an intellectual property index that
Samsung is the leading US patent holder, 24,000 ahead of IBM
Of the top eleven active US patent holders, only four are American companies. But who gets the best return on their innovation rights is less
The impact of higher patent licensing hurdles may not be fully understood
Most patent holders would agree that licensing patents for revenue has gone from bad to awful — from difficult less than a decade ago, to
Jury awards Merck $200M in patent damages, 10% of what it had sought
A California jury has awarded pharmaceutical drug company Merck $200 million, a fraction of what it had sought, for infringement of two of its patents
Validated Merck patents could mean a $3B+ windfall, after appeals
While many high-tech patents are suffering from devaluation the value of some pharmaceutical patents is soaring. Merck & Co. won a legal victory over
ipcloseup.com 